共 50 条
Avoiding Overtreatment of Ductal Carcinoma in situ
被引:7
|作者:
van der Borden, Carolien L.
[1
]
Stoffers, Saskia
[1
]
Lips, Esther H.
[1
]
Wesseling, Jelle
[1
,2
,3
]
机构:
[1] Div Mol Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Dept Pathol, Div Diagnost Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[3] Leiden Univ, Dept Pathol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
来源:
关键词:
INVASIVE BREAST-CANCER;
RADIOTHERAPY;
DCIS;
D O I:
10.1016/j.trecan.2019.05.005
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Ductal carcinoma in situ (DCIS), a precursor to invasive breast cancer (IBC), represents 25% of all breast neoplasms. Most are harmless, but some progress to IBC. Yet, almost all DCIS are treated. Learning how to distinguish harmless from hazardous DCIS will save many women with harmless DCIS the burden of overtreatment.
引用
收藏
页码:391 / 393
页数:3
相关论文